ahimsa
Senior Member (Voting Rights)
Severe people may hold answers to Long COVID. They must be included in research.
After giving several examples of research projects that have included more severe patients, they made these comments:
The Sick Times said:Several participants at the second RECOVER-TLC workshop, held on September 9–10, 2025, raised concerns that many trials currently in progress, particularly those requiring extensive in-person visits, exclude people with severe Long COVID.
Advocates urged the program to develop decentralized, home-based options and warned against “mildwashing,” or the tendency to focus primarily on less severe cases.
RECOVER-TLC needs to address this gap directly by creating study designs that allow home- and bedbound people to participate. These people represent the most clinically urgent population, yet they remain absent from the evidence base that guides care. Their exclusion is not a procedural oversight but a scientific failure, and correcting it is essential for any program committed to understanding the full spectrum of the disease.
After giving several examples of research projects that have included more severe patients, they made these comments:
The Sick Times said:These studies remind us that inclusion is not a logistical burden but a measure of a study’s integrity and vision. Making research accessible to the most severely affected is not about lowering standards; it is about meeting the true standard of science itself, understanding every part of the spectrum we aim to heal.
This principle is not new to medicine. In genetics and complex disease research, scientists often apply what is known as the extreme phenotype strategy: they focus on the most severe, resistant, or atypical cases to uncover mechanisms that may be hidden in milder forms. Studying those at the farthest ends of the spectrum amplifies biological signals and accelerates the discovery of causal pathways and potential drug targets.